Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW.

Lancet. 2004 Oct 23-29;364(9444):1519-21.

PMID:
15500897
2.

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

N Engl J Med. 2007 Mar 8;356(10):998-1008.

3.

Stent thrombosis in randomized clinical trials of drug-eluting stents.

Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE.

N Engl J Med. 2007 Mar 8;356(10):1020-9.

4.

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW.

Lancet. 2007 Feb 24;369(9562):667-78.

PMID:
17321312
5.

Late stent thrombosis after implantation of a sirolimus-eluting stent.

Kerner A, Gruberg L, Kapeliovich M, Grenadier E.

Catheter Cardiovasc Interv. 2003 Dec;60(4):505-8.

PMID:
14624431
6.

Drug-eluting stents: some bare facts.

Eisenberg MJ.

Lancet. 2004 Oct 23-29;364(9444):1466-7. No abstract available.

PMID:
15500872
7.

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C; BASKET-LATE Investigators..

J Am Coll Cardiol. 2006 Dec 19;48(12):2584-91.

8.

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G; PRODIGY Investigators..

JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008.

9.

Late angiographic stent thrombosis after sirolimus-eluting stent implantation.

Takahashi S, Kaneda H, Tanaka S, Miyashita Y, Shiono T, Taketani Y, Domae H, Matsumi J, Mizuno S, Minami Y, Sugitatsu K, Saito S.

Circ J. 2007 Feb;71(2):226-8.

10.

Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).

Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH; DES.DE Study Group..

Am J Cardiol. 2009 Nov 15;104(10):1362-9. doi: 10.1016/j.amjcard.2009.06.058.

PMID:
19892051
11.

Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.

Leon MB, Nikolsky E, Cutlip DE, Mauri L, Liberman H, Wilson H, Patterson J, Moses J, Kandzari DE; ENDEAVOR IV Investigators..

JACC Cardiovasc Interv. 2010 Oct;3(10):1043-50. doi: 10.1016/j.jcin.2010.07.008.

12.

Drug-eluting stents and stent thrombosis: a cause for concern?

Wernick MH, Jeremias A, Carrozza JP.

Coron Artery Dis. 2006 Dec;17(8):661-5. Review.

PMID:
17119373
13.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013.

14.

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.

Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R.

Circulation. 2007 May 8;115(18):2435-41.

15.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A.

N Engl J Med. 2007 Mar 8;356(10):1030-9.

16.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P.

Lancet. 2007 Sep 15;370(9591):937-48. Review.

PMID:
17869634
17.

Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.

Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-2005)..

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):41-9. doi: 10.1002/ccd.22533.

PMID:
20310019
18.

Very late thrombosis after drug-eluting stents.

Feres F, Costa JR Jr, Abizaid A.

Catheter Cardiovasc Interv. 2006 Jul;68(1):83-8. Review.

PMID:
16763989
19.

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.

Jensen LO, Tilsted HH, Thayssen P, Kaltoft A, Maeng M, Lassen JF, Hansen KN, Madsen M, Ravkilde J, Johnsen SP, Sørensen HT, Thuesen L.

EuroIntervention. 2010 Apr;5(8):898-905. doi: 10.4244/.

PMID:
20542774
20.

Late coronary thrombosis in paclitaxel-eluting stents. Case reports.

Cassin M, De Biasio M, Macor F, Burelli C, Vendrametto F, Driussi M, Nicolosi GL.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):284-8.

PMID:
17413307
Items per page

Supplemental Content

Support Center